An Immune-Related Gene-Based Signature as Prognostic Tool in Ovarian Serous Cystadenocarcinoma

Fengjuan Shi,1,* Tongning Deng,2,* Jian Mo,1 Huiru Wang,1 Jianxun Lu3,4 1Department of Gynaecology and Obstetrics, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530022, People’s Republic of China; 2Department of Gynaecology and Obstetrics, Meiao Gynae...

Full description

Bibliographic Details
Main Authors: Shi F, Deng T, Mo J, Wang H, Lu J
Format: Article
Language:English
Published: Dove Medical Press 2021-07-01
Series:International Journal of General Medicine
Subjects:
Online Access:https://www.dovepress.com/an-immune-related-gene-based-signature-as-prognostic-tool-in-ovarian-s-peer-reviewed-fulltext-article-IJGM
_version_ 1818652016582328320
author Shi F
Deng T
Mo J
Wang H
Lu J
author_facet Shi F
Deng T
Mo J
Wang H
Lu J
author_sort Shi F
collection DOAJ
description Fengjuan Shi,1,* Tongning Deng,2,* Jian Mo,1 Huiru Wang,1 Jianxun Lu3,4 1Department of Gynaecology and Obstetrics, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530022, People’s Republic of China; 2Department of Gynaecology and Obstetrics, Meiao Gynaecology and Obstetrics Hospital of Guangxi, Nanning, Guangxi, 530000, People’s Republic of China; 3Department of Medical Oncology, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530022, People’s Republic of China; 4Department of Medical Oncology, The First People’s Hospital of Nanning, Nanning, Guangxi, 530022, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jianxun LuThe Fifth Affiliated Hospital of Guangxi Medical University, 89 Qixing Road, Nanning, Guangxi, 530022, People’s Republic of ChinaTel +867712636253Email lujianxun1970@sina.comBackground: Ovarian serous cystadenocarcinoma (OSCC) is a life-threatening malignancy with poor prognosis. Therefore, the identification of immune-related genes associated with OSCC prognosis may reveal new targets of immunotherapy for OSCC.Patients and Methods: The gene expression profiles of overlapped genes were extracted by weighted gene co-expression network analysis (WGCNA) to identify immune-related modules. Significant genes were identified by univariate Cox regression analysis of model genes. Model characteristic genes were obtained by least absolute shrinkage and selection operator (LASSO) analysis and used to calculate a “signature index”. The model’s ability to predict prognosis in OSCC patients was assessed using time-dependent receiver operator characteristic curves. Differences in the biological processes and Kyoto Encyclopedia of Genes and Genomes pathways between groups with high or low signature index were assessed using gene set enrichment analysis (GSEA). The types of immune cells and their abundance in the two index groups were explored by single-sample GSEA.Results: The expression profiles of 3517 overlapped genes were extracted by WGCNA, and nine modules related to the immune system of OSCC were obtained. The expression profiles of 114 hub genes were then subjected to LASSO analysis. Among them, 10 immune-related genes were significant, of which six were identified as model characteristic genes and were used to calculate the signature index. Moreover, 24 types of immune cells were identified in the tumor microenvironment, and their abundance was explored in high- and low-signature index groups of two datasets.Conclusion: ARHGEF18, PLEKHA7, MTOR, VPS45, BRCA1, and HINT2 were identified as characteristic genes and used to develop a new immune-related gene-based signature as a promising prognostic biomarker for OSCC.Keywords: ovarian serous cystadenocarcinoma, prognostic biomarker, signature index, immune-related genes
first_indexed 2024-12-17T02:15:18Z
format Article
id doaj.art-350a1a4afac34679be112d33c74c28f5
institution Directory Open Access Journal
issn 1178-7074
language English
last_indexed 2024-12-17T02:15:18Z
publishDate 2021-07-01
publisher Dove Medical Press
record_format Article
series International Journal of General Medicine
spelling doaj.art-350a1a4afac34679be112d33c74c28f52022-12-21T22:07:25ZengDove Medical PressInternational Journal of General Medicine1178-70742021-07-01Volume 144095410467454An Immune-Related Gene-Based Signature as Prognostic Tool in Ovarian Serous CystadenocarcinomaShi FDeng TMo JWang HLu JFengjuan Shi,1,* Tongning Deng,2,* Jian Mo,1 Huiru Wang,1 Jianxun Lu3,4 1Department of Gynaecology and Obstetrics, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530022, People’s Republic of China; 2Department of Gynaecology and Obstetrics, Meiao Gynaecology and Obstetrics Hospital of Guangxi, Nanning, Guangxi, 530000, People’s Republic of China; 3Department of Medical Oncology, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530022, People’s Republic of China; 4Department of Medical Oncology, The First People’s Hospital of Nanning, Nanning, Guangxi, 530022, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jianxun LuThe Fifth Affiliated Hospital of Guangxi Medical University, 89 Qixing Road, Nanning, Guangxi, 530022, People’s Republic of ChinaTel +867712636253Email lujianxun1970@sina.comBackground: Ovarian serous cystadenocarcinoma (OSCC) is a life-threatening malignancy with poor prognosis. Therefore, the identification of immune-related genes associated with OSCC prognosis may reveal new targets of immunotherapy for OSCC.Patients and Methods: The gene expression profiles of overlapped genes were extracted by weighted gene co-expression network analysis (WGCNA) to identify immune-related modules. Significant genes were identified by univariate Cox regression analysis of model genes. Model characteristic genes were obtained by least absolute shrinkage and selection operator (LASSO) analysis and used to calculate a “signature index”. The model’s ability to predict prognosis in OSCC patients was assessed using time-dependent receiver operator characteristic curves. Differences in the biological processes and Kyoto Encyclopedia of Genes and Genomes pathways between groups with high or low signature index were assessed using gene set enrichment analysis (GSEA). The types of immune cells and their abundance in the two index groups were explored by single-sample GSEA.Results: The expression profiles of 3517 overlapped genes were extracted by WGCNA, and nine modules related to the immune system of OSCC were obtained. The expression profiles of 114 hub genes were then subjected to LASSO analysis. Among them, 10 immune-related genes were significant, of which six were identified as model characteristic genes and were used to calculate the signature index. Moreover, 24 types of immune cells were identified in the tumor microenvironment, and their abundance was explored in high- and low-signature index groups of two datasets.Conclusion: ARHGEF18, PLEKHA7, MTOR, VPS45, BRCA1, and HINT2 were identified as characteristic genes and used to develop a new immune-related gene-based signature as a promising prognostic biomarker for OSCC.Keywords: ovarian serous cystadenocarcinoma, prognostic biomarker, signature index, immune-related geneshttps://www.dovepress.com/an-immune-related-gene-based-signature-as-prognostic-tool-in-ovarian-s-peer-reviewed-fulltext-article-IJGMovarian serous cystadenocarcinomaprognostic biomarkersignature indeximmune-related genes.
spellingShingle Shi F
Deng T
Mo J
Wang H
Lu J
An Immune-Related Gene-Based Signature as Prognostic Tool in Ovarian Serous Cystadenocarcinoma
International Journal of General Medicine
ovarian serous cystadenocarcinoma
prognostic biomarker
signature index
immune-related genes.
title An Immune-Related Gene-Based Signature as Prognostic Tool in Ovarian Serous Cystadenocarcinoma
title_full An Immune-Related Gene-Based Signature as Prognostic Tool in Ovarian Serous Cystadenocarcinoma
title_fullStr An Immune-Related Gene-Based Signature as Prognostic Tool in Ovarian Serous Cystadenocarcinoma
title_full_unstemmed An Immune-Related Gene-Based Signature as Prognostic Tool in Ovarian Serous Cystadenocarcinoma
title_short An Immune-Related Gene-Based Signature as Prognostic Tool in Ovarian Serous Cystadenocarcinoma
title_sort immune related gene based signature as prognostic tool in ovarian serous cystadenocarcinoma
topic ovarian serous cystadenocarcinoma
prognostic biomarker
signature index
immune-related genes.
url https://www.dovepress.com/an-immune-related-gene-based-signature-as-prognostic-tool-in-ovarian-s-peer-reviewed-fulltext-article-IJGM
work_keys_str_mv AT shif animmunerelatedgenebasedsignatureasprognostictoolinovarianserouscystadenocarcinoma
AT dengt animmunerelatedgenebasedsignatureasprognostictoolinovarianserouscystadenocarcinoma
AT moj animmunerelatedgenebasedsignatureasprognostictoolinovarianserouscystadenocarcinoma
AT wangh animmunerelatedgenebasedsignatureasprognostictoolinovarianserouscystadenocarcinoma
AT luj animmunerelatedgenebasedsignatureasprognostictoolinovarianserouscystadenocarcinoma
AT shif immunerelatedgenebasedsignatureasprognostictoolinovarianserouscystadenocarcinoma
AT dengt immunerelatedgenebasedsignatureasprognostictoolinovarianserouscystadenocarcinoma
AT moj immunerelatedgenebasedsignatureasprognostictoolinovarianserouscystadenocarcinoma
AT wangh immunerelatedgenebasedsignatureasprognostictoolinovarianserouscystadenocarcinoma
AT luj immunerelatedgenebasedsignatureasprognostictoolinovarianserouscystadenocarcinoma